CovalentMod Profile Banner
Covalent Modifiers Profile
Covalent Modifiers

@CovalentMod

Followers
5K
Following
66
Media
424
Statuses
842

A feed for the blog https://t.co/pXYAKACULR. Discusses the covalent modification of proteins. Available on bsky and mass std don

Ottawa, Ontario
Joined April 2017
Don't wanna be here? Send us removal request.
@CovalentMod
Covalent Modifiers
1 month
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers
0
0
6
@CovalentMod
Covalent Modifiers
2 months
Design, synthesis and biological evaluation of the activity-based probes for FGFR covalent inhibitor
0
2
6
@CovalentMod
Covalent Modifiers
2 months
Discovery of a Novel Serine-Targeting Covalent Inhibitor against HCES2A for Treating Drug-induced Diarrhea and Ulcerative Colitis
0
0
6
@CovalentMod
Covalent Modifiers
2 months
Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of the mitophagy regulator USP30
0
0
2
@CovalentMod
Covalent Modifiers
2 months
Blocking C-terminal processing of KRAS4b via a direct covalent attack on the CaaX-box cysteine
0
0
1
@CovalentMod
Covalent Modifiers
2 months
Discovery of Carbodiimide Warheads to Selectively and Covalently Target Aspartic Acid in KRASG12D
0
1
7
@CovalentMod
Covalent Modifiers
2 months
Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads
0
0
4
@CovalentMod
Covalent Modifiers
2 months
Glecirasib, a potent and selective covalent KRAS G12C inhibitor exhibiting synergism 2 with cetuximab or SHP2 inhibitor JAB-3312
0
3
6
@CovalentMod
Covalent Modifiers
2 months
RT @HartungIngo: Clinical update for zoldonrasib - Ras(on)G12D selective covalent inhibitor - dosed at 1200 mg qd po (MTD previously not re….
0
10
0
@CovalentMod
Covalent Modifiers
2 months
Discovery and Optimization of a Covalent AKR1C3 Inhibitor
0
0
1
@CovalentMod
Covalent Modifiers
2 months
DCAF16-Based Covalent Degradative Handles for the Modular Design of Degraders
0
1
4
@CovalentMod
Covalent Modifiers
3 months
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 Inhibitors
0
0
4
@CovalentMod
Covalent Modifiers
3 months
Discovery and Optimization of a Covalent AKR1C3 Inhibitor
0
0
5
@CovalentMod
Covalent Modifiers
3 months
Discovery of RNA-Reactive Small Molecules Guides Design of Electrophilic Modules for RNA-Specific Covalent Binders
0
1
2
@CovalentMod
Covalent Modifiers
3 months
Identification of a phenyl ester covalent inhibitor of caseinolytic protease and analysis of the ClpP1P2 inhibition in mycobacteria
0
0
2
@CovalentMod
Covalent Modifiers
3 months
Substrate Trapping in Polyketide Synthase Thioesterase Domains: Structural Basis for Macrolactone Formation
0
0
1
@CovalentMod
Covalent Modifiers
3 months
Covalent Modification of Glutamic Acid Inspired by HaloTag Technology
0
0
2
@CovalentMod
Covalent Modifiers
3 months
If you'd like to follow Covalent Modifier content on LinkedIn, our "company page" is online
0
2
6
@CovalentMod
Covalent Modifiers
3 months
A predictive model for thiol reactivity of N-heteroaryl α-methylene–γ-lactams—a medicinally relevant covalent reactive group
0
1
6
@CovalentMod
Covalent Modifiers
4 months
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
0
0
3